Seasonal monitoring of serum IgE and blood eosinophil variability may lead to a better severe asthma phenotyping and to a correct biologic prescription

J Biol Regul Homeost Agents. 2020 Jan-Feb;34(1):315-318. doi: 10.23812/19-429-L-49.

Authors

B Sposato^{1

2}, M Scalese³, P Rogliani^{2

4}

Affiliations

¹ Azienda USL Toscana Sud-Est Pneumology Department, "Misericordia" Hospital, Grosseto.
² Experimental Medicine and Systems, "PhD program" Department of Systems Medicine University of Rome "Tor Vergata".
³ Clinic Physiology Institute, National Research Centre, Pisa, Italy.
⁴ Respiratory Unit, department of Experimental Medicine, University of Rome "Tor Vergata" Rome, Italy.

PMID: 32538068
DOI: 10.23812/19-429-L-49

No abstract available

Keywords: IgE; biologic treatment; blood eosinophils; prescription; season; severe asthma.

Publication types

Letter

MeSH terms

Asthma / classification*
Biological Products / therapeutic use*
Eosinophils / cytology*
Humans
Immunoglobulin E / blood*
Leukocyte Count
Seasons*

Substances

Biological Products
Immunoglobulin E